Outcomes from an infectious disease physician-guided evaluation of hospitalized persons under investigation for coronavirus disease 2019 (COVID-19) at a large US academic medical center.

Dugdale, Caitlin M; Turbett, Sarah E; McCluskey, Suzanne M; Zachary, Kimon C; Shenoy, Erica S; Ciaranello, Andrea L; Walensky, Rochelle P; Rosenberg, Eric S; Anahtar, Melis N; Hooper, David C; Hyle, Emily P

Dugdale, Caitlin M; Turbett, Sarah E; McCluskey, Suzanne M; Zachary, Kimon C; Shenoy, Erica S; Ciaranello, Andrea L; Walensky, Rochelle P; Rosenberg, Eric S; Anahtar, Melis N; Hooper, David C; Hyle, Emily P.

Dugdale CM; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Turbett SE; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
McCluskey SM; Harvard Medical School, Boston, Massachusetts.
Zachary KC; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Shenoy ES; Harvard Medical School, Boston, Massachusetts.
Ciaranello AL; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
Walensky RP; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Rosenberg ES; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Anahtar MN; Harvard Medical School, Boston, Massachusetts.
Hooper DC; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Hyle EP; Harvard Medical School, Boston, Massachusetts.

Infect Control Hosp Epidemiol ; 42(3): 344-347, 2021 03.

Artículo en Inglés | MEDLINE | ID: covidwho-1131957

ABSTRACT

ABSTRACT

We describe an approach to the evaluation and isolation of hospitalized persons under investigation (PUIs) for coronavirus disease 2019 (COVID-19) at a large US academic medical center. Only a small proportion (2.9%) of PUIs with 1 or more repeated severe acute respiratory coronavirus virus 2 (SARS-CoV-2) nucleic acid amplification tests (NAATs) after a negative NAAT were diagnosed with COVID-19.

Asunto(s)

Prueba de COVID-19/estadística & datos numéricos; COVID-19/diagnóstico; Aislamiento de Pacientes/estadística & datos numéricos; Pautas de la Práctica en Medicina/normas; Centros Médicos Académicos; Boston; Control de Enfermedades Transmisibles/métodos; Hospitalización; Humanos; Técnicas de Amplificación de Ácido Nucleico; Pautas de la Práctica en Medicina/organización & administración; Estudios Retrospectivos; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Aislamiento de Pacientes / Pautas de la Práctica en Medicina / Prueba de COVID-19 / COVID-19 Tipo de estudio: Estudios diagnósticos / Estudio experimental / Estudio observacional / Estudio pronóstico Límite: Humanos País/Región como asunto: America del Norte Idioma: Inglés Revista: Infect Control Hosp Epidemiol Asunto de la revista: Enfermedades Transmisibles / Enfemeria / Epidemiología / Hospitales Año: 2021 Tipo del documento: Artículo

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google